Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Willkens

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Seminars in Arthritis and Rheumatism|November 1, 1985
Worldwide clinical safety experience with diclofenacR F Willkens
Seminars in Arthritis and Rheumatism|October 1, 1990
Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritisR F Willkens
Drugs|January 1, 1990
An overview of the long-term safety experience of nabumetoneR F Willkens
JAMA|October 6, 1978
The use of nonsteroidal anti-inflammatory agentsR F Willkens
Scandinavian Journal of Rheumatology. Supplement|January 1, 1973
Double-blind crossover trial of naproxen and placebo in patients with rheumatoid arthritisR F Willkens
Arthritis and Rheumatism|March 1, 1972
ChloroquineR F Willkens
The Journal of Rheumatology|January 1, 1992
A glimpse of Martha GrahamR F Willkens
The American Journal of Medicine|October 30, 1987
Rheumatoid arthritis: clinical considerations in diagnosis and managementR F Willkens
Seminars in Arthritis and Rheumatism|October 1, 1991
Prognostic staging for therapy of rheumatoid arthritisR F Willkens
The Journal of Rheumatology. Supplement|November 1, 1992
The selection of a nonsteroidal antiinflammatory drug. Is there a difference?R F Willkens
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Seminars in Arthritis and Rheumatism|November 1, 1985
Worldwide clinical safety experience with diclofenacR F Willkens
Seminars in Arthritis and Rheumatism|October 1, 1990
Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritisR F Willkens
Drugs|January 1, 1990
An overview of the long-term safety experience of nabumetoneR F Willkens
JAMA|October 6, 1978
The use of nonsteroidal anti-inflammatory agentsR F Willkens
Scandinavian Journal of Rheumatology. Supplement|January 1, 1973
Double-blind crossover trial of naproxen and placebo in patients with rheumatoid arthritisR F Willkens
Arthritis and Rheumatism|March 1, 1972
ChloroquineR F Willkens
The Journal of Rheumatology|January 1, 1992
A glimpse of Martha GrahamR F Willkens
The American Journal of Medicine|October 30, 1987
Rheumatoid arthritis: clinical considerations in diagnosis and managementR F Willkens
Seminars in Arthritis and Rheumatism|October 1, 1991
Prognostic staging for therapy of rheumatoid arthritisR F Willkens
The Journal of Rheumatology. Supplement|November 1, 1992
The selection of a nonsteroidal antiinflammatory drug. Is there a difference?R F Willkens
Pageof 8